CCRC Protocol Deviations & Amendments 1 — Questions and Answers
Question 1: What is a protocol deviation in the context of clinical research?
- A change to the protocol approved in advance by the IRB
- Any unplanned departure from the procedures defined in the approved protocol (Correct answer)
- A formal modification to the protocol submitted by the sponsor
- An adverse event directly caused by study procedures
Correct answer: Any unplanned departure from the procedures defined in the approved protocol
A protocol deviation is any unplanned departure from the approved procedures outlined in the study protocol.
Question 2: Which of the following BEST distinguishes a protocol violation from a protocol deviation?
- Violations are always intentional; deviations are always accidental
- Violations require sponsor approval; deviations require IRB approval
- Violations significantly affect participant safety or data integrity; deviations are minor departures (Correct answer)
- Violations are reported to the FDA; deviations are only reported internally
Correct answer: Violations significantly affect participant safety or data integrity; deviations are minor departures
Protocol violations are deviations that significantly affect participant rights, safety, welfare, or data integrity, whereas deviations are typically minor departures.
Question 3: When must a protocol amendment be submitted to the IRB for review and approval?
- Only when the amendment changes the primary endpoint
- Before implementing any change to the approved protocol (Correct answer)
- Within 30 days after implementing the change
- Only when the sponsor formally requests IRB review
Correct answer: Before implementing any change to the approved protocol
Per ICH GCP E6(R2), any amendments to the protocol must be submitted to the IRB and approved before implementation, unless an immediate safety deviation is required.
Question 4: Which type of protocol deviation typically requires immediate reporting to the sponsor?
- Minor administrative deviations such as missed phone calls
- Deviations that affect participant safety or data integrity (Correct answer)
- Deviations related to scheduling of non-critical assessments
- Deviations involving questionnaire completion errors only
Correct answer: Deviations that affect participant safety or data integrity
Deviations that may affect participant safety or the integrity of study data require prompt reporting to the sponsor per GCP guidelines.
Question 5: What is the FIRST action a CRC should take upon identifying a protocol deviation?
- Immediately notify the FDA
- Document the deviation and notify the principal investigator (Correct answer)
- Terminate the affected participant from the study
- Submit a protocol amendment to the IRB
Correct answer: Document the deviation and notify the principal investigator
The first step is to document the deviation thoroughly and notify the PI, who is ultimately responsible for protocol compliance at the site.
Question 6: A participant received a study drug dose 20% higher than specified in the protocol due to a calculation error. This event is BEST classified as:
- A serious adverse event requiring expedited safety reporting only
- A protocol deviation requiring documentation and reporting to the sponsor (Correct answer)
- An expected drug reaction to be noted in the participant's medical record
- A minor administrative error requiring no formal action
Correct answer: A protocol deviation requiring documentation and reporting to the sponsor
An incorrect dosing error is a protocol deviation (and likely a major one) that must be documented and reported to the sponsor and potentially the IRB.
Question 7: Protocol amendments that increase risk to participants or substantially change the study design are classified as:
- Minor amendments requiring only expedited IRB review
- Significant amendments requiring full IRB board review (Correct answer)
- Administrative amendments that can be implemented immediately
- Urgent amendments that bypass IRB review entirely
Correct answer: Significant amendments requiring full IRB board review
Amendments that increase participant risk or substantially alter the study design require full IRB board review rather than expedited or administrative review.
What is a protocol deviation in the context of clinical research?